Qorvo Biotechnologies Awarded $4.1 Million National Institutes of Health Contract for SARS-CoV-2/ Flu Combo and Antigen Pooling

Go back to Qorvo Biotechnologies Awarded $4.1 Million National Institutes of Health Contract for SARS-CoV-2/ Flu Combo and Antigen Pooling
(NASDAQ: QRVO) Delayed: 87.57 -3.31 (3.64%)
Previous Close $90.88    52 Week High $64.80 
Open $90.61    52 Week Low $33.30 
Day High $92.74    P/E N/A 
Day Low $86.97    EPS $0.00 
Volume 1,364,751